Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ppt download
Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar
Polo-like kinase 4: the odd one out of the family | Cell Division | Full Text
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers | PNAS
Polo-like Kinase 4 Shapes Up - ScienceDirect
![PDF] The Human Polo-like Kinase 4 is a Regulator of Centrosome Duplication | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a45c763a118675cd3ab18051fa972f1c14c72ec/10-Figure2-1.png "PDF] The Human Polo-like Kinase 4 is a Regulator of Centrosome Duplication | Semantic Scholar")
PDF] The Human Polo-like Kinase 4 is a Regulator of Centrosome Duplication | Semantic Scholar
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS
Goat anti-Human PLK4 antibody (ABIN184701)
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research
Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar
Polo-like Kinase 4 Autodestructs by Generating Its Slimb-Binding Phosphodegron - ScienceDirect
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer
Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The Polo-like Kinase Inhibitor
Goat anti-Human PLK4 antibody (ABIN184701)
